Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$56.27 - $73.77 $660,103 - $865,395
11,731 Added 310.34%
15,511 $1.07 Million
Q4 2023

Feb 01, 2024

BUY
$59.06 - $75.72 $28,466 - $36,497
482 Added 14.61%
3,780 $279,000
Q3 2023

Nov 09, 2023

BUY
$65.94 - $99.04 $16,155 - $24,264
245 Added 8.02%
3,298 $224,000
Q2 2023

Aug 29, 2023

SELL
$62.68 - $95.05 $12,724 - $19,295
-203 Reduced 6.23%
3,053 $286,000
Q1 2023

May 04, 2023

BUY
$47.19 - $70.77 $153,650 - $230,427
3,256 New
3,256 $220,000
Q2 2022

Jul 13, 2022

BUY
$35.61 - $76.23 $19,158 - $41,011
538 Added 1.76%
31,037 $1.22 Million
Q1 2022

May 05, 2022

BUY
$57.56 - $82.54 $110,860 - $158,972
1,926 Added 6.74%
30,499 $2.13 Million
Q4 2021

Jan 24, 2022

BUY
$72.5 - $100.68 $16,530 - $22,955
228 Added 0.8%
28,573 $2.22 Million
Q3 2021

Oct 22, 2021

SELL
$90.24 - $124.05 $223,975 - $307,892
-2,482 Reduced 8.05%
28,345 $2.71 Million
Q2 2021

Jul 23, 2021

BUY
$93.66 - $139.27 $147,608 - $219,489
1,576 Added 5.39%
30,827 $3.83 Million
Q1 2021

Apr 09, 2021

SELL
$116.57 - $155.01 $882,318 - $1.17 Million
-7,569 Reduced 20.56%
29,251 $3.86 Million
Q4 2020

Feb 05, 2021

SELL
$99.61 - $142.12 $629,136 - $897,629
-6,316 Reduced 14.64%
36,820 $4.88 Million
Q3 2020

Nov 06, 2020

SELL
$72.92 - $102.01 $577,599 - $808,021
-7,921 Reduced 15.51%
43,136 $4.4 Million
Q2 2020

Jul 30, 2020

BUY
$55.75 - $92.75 $837,922 - $1.39 Million
15,030 Added 41.72%
51,057 $4.44 Million
Q1 2020

May 08, 2020

SELL
$37.9 - $104.44 $200,491 - $552,487
-5,290 Reduced 12.8%
36,027 $2.09 Million
Q4 2019

Jan 28, 2020

BUY
$77.66 - $99.74 $833,058 - $1.07 Million
10,727 Added 35.07%
41,317 $3.82 Million
Q3 2019

Nov 05, 2019

BUY
$90.37 - $122.49 $393,651 - $533,566
4,356 Added 16.6%
30,590 $2.76 Million
Q2 2019

Jul 09, 2019

BUY
$89.51 - $118.04 $282,493 - $372,534
3,156 Added 13.68%
26,234 $3.1 Million
Q1 2019

Apr 05, 2019

BUY
$61.98 - $96.5 $1.43 Million - $2.23 Million
23,078 New
23,078 $2 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Efg Asset Management (Americas) Corp. Portfolio

Follow Efg Asset Management (Americas) Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (Americas) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (Americas) Corp. with notifications on news.